Literature DB >> 6430899

Activation of protein formation and cell division by bradykinin and des-Arg9-bradykinin.

R H Goldstein, M Wall.   

Abstract

We employed des-Arg9-bradykinin to investigate the relation between bradykinin-induced prostaglandin (PG) synthesis and bradykinin-induced protein accumulation. In this feedback control system, bradykinin-induced PG synthesis limits bradykinin-induced protein production. At low concentration (5 X 10(-8) M), des-Arg9-bradykinin was significantly less active than bradykinin in stimulating the formation of prostaglandins by human fetal lung fibroblasts in culture. At high concentration (5 X 10(-6) M), bradykinin induced a 24% increase in protein formation, while des-Arg9-bradykinin induced a 61% increase in collagen formation and an 80% increase in total protein accumulation. In the presence of indomethacin, bradykinin-induced protein formation was increased further, whereas des-Arg9-bradykinin-induced protein formation was unchanged. The bradykinin derivative increased the production of types I and III procollagens without affecting the distribution of procollagen types. The incorporation of [3H]thymidine into DNA in lung fibroblast cultures was increased 3-fold by des-Arg9-bradykinin alone or by bradykinin in combination with indomethacin. Des-Arg9-[Leu8]bradykinin inhibited the des-Arg9-bradykinin-induced protein formation and cell division. These data indicate that both bradykinin and des-Arg9-bradykinin stimulate protein formation and cell division; des-Arg9-bradykinin alone stimulates protein formation and cell division without activating PG synthesis and PG feedback control.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430899

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

2.  Bradykinin stimulates NF-kappaB activation and interleukin 1beta gene expression in cultured human fibroblasts.

Authors:  Z K Pan; B L Zuraw; C C Lung; E R Prossnitz; D D Browning; R D Ye
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 3.  Kinin receptors.

Authors:  F Marceau; D R Bachvarov
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

4.  The B1-agonist [des-Arg10]-kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts.

Authors:  J P Schanstra; E Bataillé; M E Marin Castaño; Y Barascud; C Hirtz; J B Pesquero; C Pecher; F Gauthier; J P Girolami; J L Bascands
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

5.  A phosphoinositide-linked peptide response in astrocytes: evidence for regional heterogeneity.

Authors:  A J Cholewinski; M R Hanley; G P Wilkin
Journal:  Neurochem Res       Date:  1988-04       Impact factor: 3.996

6.  Bradykinin binding sites in healthy and carcinomatous human lung.

Authors:  A Trifilieff; E Lach; P Dumont; J P Gies
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Induction of kinin B1 receptor-dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery.

Authors:  D Pruneau; J M Luccarini; C Robert; P Bélichard
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

8.  [Leu8]des-Arg9-bradykinin inhibits the angiogenic effect of bradykinin and interleukin-1 in rats.

Authors:  D E Hu; T P Fan
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

9.  Implication of the bradykinin receptors in antigen-induced pulmonary inflammation in mice.

Authors:  Jadranka Eric; Bichoy H Gabra; Pierre Sirois
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

10.  The G proteins of the G alpha i and G alpha q family couple the bradykinin receptor to the release of endothelium-derived relaxing factor.

Authors:  J K Liao; C J Homcy
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.